vs

Side-by-side financial comparison of ASSEMBLY BIOSCIENCES, INC. (ASMB) and LIGHTPATH TECHNOLOGIES INC (LPTH). Click either name above to swap in a different company.

LIGHTPATH TECHNOLOGIES INC is the larger business by last-quarter revenue ($16.4M vs $10.8M, roughly 1.5× ASSEMBLY BIOSCIENCES, INC.). LIGHTPATH TECHNOLOGIES INC runs the higher net margin — -57.5% vs -85.2%, a 27.7% gap on every dollar of revenue. On growth, LIGHTPATH TECHNOLOGIES INC posted the faster year-over-year revenue change (120.2% vs 57.6%). LIGHTPATH TECHNOLOGIES INC produced more free cash flow last quarter ($2.0M vs $-15.2M).

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

LightPath Technologies Inc designs, manufactures and distributes high-precision optical components and assemblies, including aspheric lenses, infrared optics, and fiber optic products. It serves global clients across industrial automation, aerospace, defense, medical imaging, and telecommunications sectors.

ASMB vs LPTH — Head-to-Head

Bigger by revenue
LPTH
LPTH
1.5× larger
LPTH
$16.4M
$10.8M
ASMB
Growing faster (revenue YoY)
LPTH
LPTH
+62.6% gap
LPTH
120.2%
57.6%
ASMB
Higher net margin
LPTH
LPTH
27.7% more per $
LPTH
-57.5%
-85.2%
ASMB
More free cash flow
LPTH
LPTH
$17.1M more FCF
LPTH
$2.0M
$-15.2M
ASMB

Income Statement — Q3 FY2025 vs Q2 FY2026

Metric
ASMB
ASMB
LPTH
LPTH
Revenue
$10.8M
$16.4M
Net Profit
$-9.2M
$-9.4M
Gross Margin
36.8%
Operating Margin
-100.9%
-52.6%
Net Margin
-85.2%
-57.5%
Revenue YoY
57.6%
120.2%
Net Profit YoY
4.3%
-260.1%
EPS (diluted)
$-0.72
$-0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASMB
ASMB
LPTH
LPTH
Q4 25
$16.4M
Q3 25
$10.8M
$15.1M
Q2 25
$9.6M
$12.2M
Q1 25
$9.4M
$9.2M
Q4 24
$7.4M
$7.4M
Q3 24
$6.8M
$8.4M
Q2 24
$8.5M
$8.6M
Q1 24
$5.8M
$7.7M
Net Profit
ASMB
ASMB
LPTH
LPTH
Q4 25
$-9.4M
Q3 25
$-9.2M
$-2.9M
Q2 25
$-10.2M
$-7.1M
Q1 25
$-8.8M
$-3.6M
Q4 24
$-2.6M
Q3 24
$-9.6M
$-1.6M
Q2 24
$-11.2M
$-2.4M
Q1 24
$-9.1M
$-2.6M
Gross Margin
ASMB
ASMB
LPTH
LPTH
Q4 25
36.8%
Q3 25
29.8%
Q2 25
22.0%
Q1 25
29.1%
Q4 24
26.0%
Q3 24
33.9%
Q2 24
29.2%
Q1 24
20.9%
Operating Margin
ASMB
ASMB
LPTH
LPTH
Q4 25
-52.6%
Q3 25
-100.9%
-16.6%
Q2 25
-115.2%
-38.0%
Q1 25
-105.5%
-36.3%
Q4 24
-33.5%
Q3 24
-160.1%
-16.4%
Q2 24
-143.0%
-25.6%
Q1 24
-185.5%
-33.6%
Net Margin
ASMB
ASMB
LPTH
LPTH
Q4 25
-57.5%
Q3 25
-85.2%
-19.2%
Q2 25
-105.9%
-57.8%
Q1 25
-93.6%
-39.1%
Q4 24
-35.2%
Q3 24
-140.4%
-19.3%
Q2 24
-130.7%
-27.3%
Q1 24
-156.9%
-33.7%
EPS (diluted)
ASMB
ASMB
LPTH
LPTH
Q4 25
$-0.20
Q3 25
$-0.72
$-0.07
Q2 25
$-1.33
$0.19
Q1 25
$-1.17
$-0.44
Q4 24
$-0.07
Q3 24
$-1.51
$-0.04
Q2 24
$-1.98
$-0.15
Q1 24
$-1.66
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASMB
ASMB
LPTH
LPTH
Cash + ST InvestmentsLiquidity on hand
$22.5M
$73.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$182.7M
$77.9M
Total Assets
$240.0M
$148.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASMB
ASMB
LPTH
LPTH
Q4 25
$73.6M
Q3 25
$22.5M
Q2 25
$24.0M
$4.9M
Q1 25
$23.4M
Q4 24
$38.3M
Q3 24
$28.5M
Q2 24
$19.2M
Q1 24
$18.7M
Total Debt
ASMB
ASMB
LPTH
LPTH
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$535.0K
Q1 24
$599.4K
Stockholders' Equity
ASMB
ASMB
LPTH
LPTH
Q4 25
$77.9M
Q3 25
$182.7M
$21.4M
Q2 25
$18.1M
$15.6M
Q1 25
$27.1M
$15.7M
Q4 24
$33.4M
$26.7M
Q3 24
$26.0M
$29.4M
Q2 24
$34.7M
$30.2M
Q1 24
$32.6M
$31.7M
Total Assets
ASMB
ASMB
LPTH
LPTH
Q4 25
$148.6M
Q3 25
$240.0M
$87.3M
Q2 25
$80.8M
$81.5M
Q1 25
$99.0M
$81.4M
Q4 24
$119.2M
$45.8M
Q3 24
$100.3M
$48.4M
Q2 24
$115.3M
$48.1M
Q1 24
$119.9M
$49.7M
Debt / Equity
ASMB
ASMB
LPTH
LPTH
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.02×
Q1 24
0.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASMB
ASMB
LPTH
LPTH
Operating Cash FlowLast quarter
$-15.1M
$2.8M
Free Cash FlowOCF − Capex
$-15.2M
$2.0M
FCF MarginFCF / Revenue
-140.7%
12.0%
Capex IntensityCapex / Revenue
0.4%
5.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-6.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASMB
ASMB
LPTH
LPTH
Q4 25
$2.8M
Q3 25
$-15.1M
$-1.1M
Q2 25
$-16.8M
$-2.6M
Q1 25
$-23.4M
$-3.2M
Q4 24
$-51.1M
$-737.4K
Q3 24
$-15.2M
$-1.7M
Q2 24
$-17.1M
$64.7K
Q1 24
$-18.4M
$-394.2K
Free Cash Flow
ASMB
ASMB
LPTH
LPTH
Q4 25
$2.0M
Q3 25
$-15.2M
$-1.2M
Q2 25
$-3.3M
Q1 25
$-3.7M
Q4 24
$-51.1M
$-817.8K
Q3 24
$-1.8M
Q2 24
$-17.1M
$-225.5K
Q1 24
$-18.4M
$-802.5K
FCF Margin
ASMB
ASMB
LPTH
LPTH
Q4 25
12.0%
Q3 25
-140.7%
-8.1%
Q2 25
-27.3%
Q1 25
-40.0%
Q4 24
-695.2%
-11.0%
Q3 24
-21.2%
Q2 24
-200.6%
-2.6%
Q1 24
-317.7%
-10.4%
Capex Intensity
ASMB
ASMB
LPTH
LPTH
Q4 25
5.3%
Q3 25
0.4%
0.5%
Q2 25
0.0%
5.6%
Q1 25
0.0%
4.6%
Q4 24
0.4%
1.1%
Q3 24
0.0%
0.9%
Q2 24
0.2%
3.4%
Q1 24
0.2%
5.3%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASMB
ASMB

Segment breakdown not available.

LPTH
LPTH

Other$7.9M48%
Infrared Components$5.0M31%
Visible Components$3.4M21%

Related Comparisons